The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamoto, I.
Right arrow Articles by Kurimoto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, I.
Right arrow Articles by Kurimoto, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 162: 3202-3211.
Copyright © 1999 by The American Association of Immunologists

Development of CD8+ Effector T Cells Is Differentially Regulated by IL-18 and IL-12

Iwao Okamoto1, Keizo Kohno, Tadao Tanimoto, Hakuo Ikegami and Masashi Kurimoto

Fujisaki Institute, Hayashibara Biochemical Laboratories, Okayama, Japan

We investigated the effects of IL-18 on the development of CD8+ effector T cells in DBA/2 anti-BDF1 whole spleen cell MLC and compared the results with those of IL-12. Addition of IL-18 to the MLC resulted in a twofold increase in CD8/CD4 ratios compared with the control cultures when cells were expanded in IL-2-containing medium following MLC. Purified CD8+ T cells recovered from the IL-18-stimulated MLC produced 20- to 30-fold more IFN-{gamma} after secondary stimulation with C57BL/6 spleen cells or anti-CD3 mAb, and exhibited strong allospecific CTL activity. Neither IL-18 nor IL-18-supplemented culture supernatants from DBA/2 anti-BDF1 MLC induced type I CD8+ effector T cells when purified CD8+ T cells were used as responder cells in primary MLC. Furthermore, CD4+ T cell depletion from the responder cells abrogated the IL-18-induced increase in secondary IFN-{gamma} production by CD8+ T cells, suggesting that IL-18-induced type I effector CD8+ T cell development was CD4+ T cell dependent. In marked contrast, adding IL-12 to primary MLC decreased CD8/CD4 ratios by 50% and suppressed secondary IFN-{gamma} production and CTL activity by CD8+ T cells regardless of concentration, whereas Th1 development was promoted by IL-12. Moreover, both IL-12 and IL-18 efficiently induced type I CD8+ effector T cells in C57BL/6 anti-BDF1 MLC. These findings show that IL-18 plays an important role in the generation of type I CD8+ effector T cells, and further suggest that functional maturation of CD8+ T cells is differentially regulated by IL-18 and IL-12.




This article has been cited by other articles:


Home page
J. Virol.Home page
S. Nandakumar, S. N. Woolard, D. Yuan, B. T. Rouse, and U. Kumaraguru
Natural Killer Cells as Novel Helpers in Anti-Herpes Simplex Virus Immune Response
J. Virol., November 1, 2008; 82(21): 10820 - 10831.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. Li, S.-i. Kashiwamura, H. Ueda, A. Sekiyama, and H. Okamura
Protection of CD8+ T cells from activation-induced cell death by IL-18
J. Leukoc. Biol., July 1, 2007; 82(1): 142 - 151.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K.-i. Yamanaka, R. Clark, R. Dowgiert, D. Hurwitz, M. Shibata, B. E. Rich, K. Hirahara, D. A. Jones, S. Eapen, H. Mizutani, et al.
Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma
Clin. Cancer Res., January 15, 2006; 12(2): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-K. Min, Y. Maeda, K. Lowler, C. Liu, S. Clouthier, D. Lofthus, E. Weisiger, J. L. M. Ferrara, and P. Reddy
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation
Blood, November 15, 2004; 104(10): 3393 - 3399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Vankayalapati, P. Klucar, B. Wizel, S. E. Weis, B. Samten, H. Safi, H. Shams, and P. F. Barnes
NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen
J. Immunol., January 1, 2004; 172(1): 130 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail
In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18
J. Immunol., September 15, 2003; 171(6): 2953 - 2959.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. M. Gherardi, J. C. Ramirez, and M. Esteban
IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system
J. Gen. Virol., August 1, 2003; 84(8): 1961 - 1972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wang, C. Feliciani, B. G. Howell, I. Freed, Q. Cai, H. Watanabe, and D. N. Sauder
Contribution of Langerhans Cell-Derived IL-18 to Contact Hypersensitivity
J. Immunol., April 1, 2002; 168(7): 3303 - 3308.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Reddy, T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, K. Lowler, and J. L.M. Ferrara
Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis
J. Exp. Med., November 12, 2001; 194(10): 1433 - 1440.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Neighbors, X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra
A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria monocytogenes That Extends Beyond Its Effects on Interferon {gamma} Production
J. Exp. Med., August 6, 2001; 194(3): 343 - 354.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Itoi, Y. Fujimori, H. Tsutsui, K. Matsui, S. Futatsugi, H. Okamura, H. Hara, T. Hada, E. Kakishita, and K. Nakanishi
Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease
Blood, July 1, 2001; 98(1): 235 - 237.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Vankayalapati, B. Wizel, D. L. Lakey, Y. Zhang, K. A. Coffee, D. E. Griffith, and P. F. Barnes
T Cells Enhance Production of IL-18 by Monocytes in Response to an Intracellular Pathogen
J. Immunol., June 1, 2001; 166(11): 6749 - 6753.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Horwood, J. Elliott, T. J. Martin, and M. T. Gillespie
IL-12 Alone and in Synergy with IL-18 Inhibits Osteoclast Formation In Vitro
J. Immunol., April 15, 2001; 166(8): 4915 - 4921.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. Dittmer, K. E. Peterson, R. Messer, I. M. Stromnes, B. Race, and K. J. Hasenkrug
Role of Interleukin-4 (IL-4), IL-12, and Gamma Interferon in Primary and Vaccine-Primed Immune Responses to Friend Retrovirus Infection
J. Virol., January 15, 2001; 75(2): 654 - 660.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu
Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model
J. Immunol., January 15, 2001; 166(2): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Tanaka, W. Hashimoto, H. Okamura, P. D. Robbins, M. T. Lotze, and H. Tahara
Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells
Cancer Res., September 1, 2000; 60(17): 4838 - 4844.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
P. Brossart, A. Zobywalski, F. Grünebach, L. Behnke, G. Stuhler, V. L. Reichardt, L. Kanz, and W. Brugger
Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells
Cancer Res., August 1, 2000; 60(16): 4485 - 4492.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto
IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
J. Immunol., June 1, 2000; 164(11): 6067 - 6074.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Campbell, S. L. Kunkel, R. M. Strieter, and N. W. Lukacs
Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation
J. Immunol., January 15, 2000; 164(2): 1096 - 1102.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Hansen, V. P. Yeung, G. Berry, D. T. Umetsu, and R. H. DeKruyff
Vaccination with Heat-Killed Listeria as Adjuvant Reverses Established Allergen-Induced Airway Hyperreactivity and Inflammation: Role of CD8+ T Cells and IL-18
J. Immunol., January 1, 2000; 164(1): 223 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Schober, C. T. Kuo, K. S. Schluns, L. Lefrancois, J. M. Leiden, and S. C. Jameson
Expression of the Transcription Factor Lung Kruppel-Like Factor Is Regulated by Cytokines and Correlates with Survival of Memory T Cells In Vitro and In Vivo
J. Immunol., October 1, 1999; 163(7): 3662 - 3667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.